US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 20.749
- -1.451-6.53%
Trading Nov 21 10:35 ET
726.20MMarket Cap-54603P/E (TTM)
23.790High19.960Low39.74KVolume23.060Open22.200Pre Close904.89KTurnover0.17%Turnover RatioLossP/E (Static)35.00MShares33.00052wk High2.14P/B485.65MFloat Cap10.06852wk Low--Dividend TTM23.41MShs Float40838092.445Historical High--Div YieldTTM17.25%Amplitude10.068Historical Low22.773Avg Price1Lot Size
About Oruka Therapeutics Company
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Company Profile
SymbolORKA
Company NameOruka Therapeutics
Listing DateAug 8, 1997
CEODr. Lawrence Otto Klein, PhD
MarketNASDAQ
Fiscal Year Ends12-31
Address855 Oak Grove Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-650-606-7910
Websitehttp://www.orukatx.com
Company Executives
- Name
- Position
- Salary
- Dr. Lawrence Otto Klein, PhD
- Director, President and Chief Executive Officer
- --
- Dr. Joana Goncalves, M.D.
- Chief Medical Officer
- --
- Arjun Agarwal
- Senior Vice President, Finance and Treasurer
- --
- Dr. Samarth Kulkarni, PhD
- Chairman of the Board
- --
- Peter Harwin
- Independent Director
- --
- Dr. Carl Dambkowski, M.D.
- Independent Director
- --
- Dr. Cameron Turtle, D.Phil.
- Independent Director
- --
- Kristine M. Ball
- Independent Director
- --
- Paul T. Quinlan PhD
- General Counsel and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data